A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases. Issue 4 (26th February 2019)

• Record Type: Journal Article
• Authors: Nakamura, Naohiko; Kinami, Shinichi; Fujii, Yoritaka; Miura, Seiko; Fujita, Jun; Kaida, Daisuke; Tomita, Yasuto; Miyata, Takashi; Fujita, Hideto; Ueda, Nobuhiko; Kosaka, Takeo
• Is Part Of: Clinical case reports. Volume 7:Issue 4(2019)
• Page Start: 714
• Page End: 718
• Publication Date: 2019-02-26
• Subjects: capecitabine -- gastric cancer -- trastuzumab; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.2056
• Languages: English
• ISSNs: 2050-0904

Abstract

Key Clinical Message: When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients. Abstract : When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.